Part I: Epidemiology, pathophysiology, and clinical considerations of primary and secondary Raynaud's phenomenon

被引:5
作者
Curtiss, Paul [1 ]
Svigos, Katerina [1 ]
Schwager, Zachary [2 ]
Lo Sicco, Kristen [1 ,4 ]
Franks Jr, Andrew G. [1 ,3 ]
机构
[1] NYU, Grossman Sch Med, Ronald O Perelman Dept Dermatol, New York, NY USA
[2] Lahey Hosp & Med Ctr, Dept Dermatol, Burlington, MA USA
[3] NYU, Sch Med, Dept Internal Med, Div Rheumatol, New York, NY USA
[4] Ronald O Perelman Dept Dermatol, 240 E 38th St,11th Floor, New York, NY 10016 USA
关键词
connective tissue disease; erythematosus; medical dermatology; Raynaud's phenomenon; scleroderma; systemic lupus; SYSTEMIC-SCLEROSIS SCLERODERMA; NITRIC-OXIDE SYNTHASE; DIGITAL ULCERS; ANTIPHOSPHOLIPID ANTIBODIES; NAILFOLD CAPILLAROSCOPY; VASCULAR RETINOPATHY; GROWTH-FACTOR; DISEASE; BOSENTAN; INVOLVEMENT;
D O I
10.1016/j.jaad.2022.06.1199
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Raynaud's phenomenon (RP) is a relatively common disease with both primary and secondary forms. It is well understood as a vasospastic condition affecting the acral and digital arteries, resulting in characteristic, well-demarcated color changes typically in the hands and feet in response to cold or stress. Secondary RP (SRP) has been described in association with a variety of rheumatologic and nonrheumatologic diseases, environmental exposures, and/or medications. While both primary RP and SRP may impact the quality of life, SRP may lead to permanent and potentially devastating tissue destruction when undiagnosed and untreated. It is therefore crucial for dermatologists to distinguish between primary and secondary disease forms early in clinical evaluation, investigate potential underlying causes, and risk stratify SRP patients for the development of associated autoimmune connective tissue disease. The epidemiology, pathogenesis, and clinical presentation and diagnosis of both forms of RP are described in detail in this review article.
引用
收藏
页码:223 / 234
页数:12
相关论文
共 80 条
  • [1] Use of bosentan for digital ulcers related to systemic sclerosis: a real-life retrospective French study of 89 patients treated since specific approval
    Agard, C.
    Carpentier, P. H.
    Mouthon, L.
    Clerson, P.
    Gressin, V.
    Berezne, A.
    Diot, E.
    Jego, P.
    Lok, C.
    Sparsa, A.
    Chatelus, E.
    Van Kien, A. Khau
    Quere, I.
    Sibilia, J.
    Hachulla, E.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 (05) : 398 - 402
  • [2] Systemic sclerosis
    Allanore, Yannick
    Simms, Robert
    Distler, Oliver
    Trojanowska, Maria
    Pope, Janet
    Denton, Christopher P.
    Varga, John
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [3] Raynaud's phenomenon: Pathogenesis and management
    Bakst, Richard
    Merola, Joseph F.
    Franks, Andrew G., Jr.
    Sanchez, Miguel
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 59 (04) : 633 - 653
  • [4] CHANGES IN SKIN BLOOD-FLOW DURING THE MENSTRUAL-CYCLE - THE INFLUENCE OF THE MENSTRUAL-CYCLE ON THE PERIPHERAL-CIRCULATION IN HEALTHY FEMALE VOLUNTEERS
    BARTELINK, ML
    WOLLERSHEIM, H
    THEEUWES, A
    VANDUREN, D
    THIEN, T
    [J]. CLINICAL SCIENCE, 1990, 78 (05) : 527 - 532
  • [5] Hypoxia Hypoxia in the pathogenesis of systemic sclerosis
    Beyer, Christian
    Schett, Georg
    Gay, Steffen
    Distler, Oliver
    Distler, Joerg H. W.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2009, 11 (02) : 220
  • [6] Absence of Scleroderma pattern at nail fold capillaroscopy valuable in the exclusion of Scleroderma in unselected patients with Raynaud's Phenomenon
    Bissell, Lesley-Anne
    Abignano, Giuseppina
    Emery, Paul
    Del Galdo, Francesco
    Buch, Maya H.
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2016, 17
  • [7] Bunker CB, 1996, BRIT J DERMATOL, V134, P399
  • [8] Raynaud's phenomenon and antiphospholipid antibodies in systemic lupus erythematosus: is there an association?
    Caccavo, D
    Del Porto, F
    Garzia, P
    Mitterhofer, AP
    Galluzzo, S
    Rigon, A
    Vadacca, M
    Navajas, MF
    Amoroso, A
    Afeltra, A
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (10) : 1003 - 1005
  • [9] CAMPBELL P M, 1975, Seminars in Arthritis and Rheumatism, V4, P351, DOI 10.1016/0049-0172(75)90017-7
  • [10] RELATIONSHIP OF HYPERTENSION AND RENAL-FAILURE IN SCLERODERMA (PROGRESSIVE-SYSTEMIC-SCLEROSIS) TO STRUCTURAL AND FUNCTIONAL ABNORMALITIES OF RENAL CORTICAL CIRCULATION
    CANNON, PJ
    HASSAR, M
    CASE, DB
    CASARELLA, WJ
    SOMMERS, SC
    LEROY, EC
    [J]. MEDICINE, 1974, 53 (01) : 1 - 46